G
Gregor Broessner
Researcher at Innsbruck Medical University
Publications - 83
Citations - 2620
Gregor Broessner is an academic researcher from Innsbruck Medical University. The author has contributed to research in topics: Migraine & Subarachnoid hemorrhage. The author has an hindex of 24, co-authored 74 publications receiving 2044 citations. Previous affiliations of Gregor Broessner include University of Innsbruck.
Papers
More filters
Journal ArticleDOI
A Controlled Trial of Erenumab for Episodic Migraine.
Peter J. Goadsby,Uwe Reuter,Yngve Hallström,Gregor Broessner,Jo H. Bonner,Feng Zhang,Sandhya Sapra,Hernan Picard,Daniel D. Mikol,Robert A. Lenz +9 more
TL;DR: Erenumab administered subcutaneously at a monthly dose of 70 mg or 140 mg significantly reduced migraine frequency, the effects of migraines on daily activities, and the use of acute migraine–specific medication over a period of 6 months.
Journal ArticleDOI
Accidental hypothermia-an update The content of this review is endorsed by the International Commission for Mountain Emergency Medicine (ICAR MEDCOM)
Peter Paal,Peter Paal,Peter Paal,Les Gordon,Giacomo Strapazzon,Monika Brodmann Maeder,Monika Brodmann Maeder,Gabriel Putzer,Beat H. Walpoth,Michael Wanscher,Doug Brown,Doug Brown,Michael Holzer,Gregor Broessner,Hermann Brugger +14 more
TL;DR: The hospital use of minimally-invasive rewarming for non-arrested, otherwise healthy, patients with primary hypothermia and stable vital signs has the potential to substantially decrease morbidity and mortality for these patients.
Journal ArticleDOI
Prophylactic, Endovascularly Based, Long-Term Normothermia in ICU Patients With Severe Cerebrovascular Disease. Bicenter Prospective, Randomized Trial
Gregor Broessner,Ronny Beer,Peter Lackner,Raimund Helbok,Marlene Fischer,Bettina Pfausler,Janelle Rhorer,Lea Küppers-Tiedt,Dietmar Schneider,Erich Schmutzhard +9 more
TL;DR: Long-term, catheter-based, prophylactic normothermia significantly reduces fever burden in neurointensive care unit patients with severe cerebrovascular disease and is not associated with increased major adverse events.
Journal ArticleDOI
Efficacy of silver nanoparticles-impregnated external ventricular drain catheters in patients with acute occlusive hydrocephalus
Peter Lackner,Ronny Beer,Gregor Broessner,Raimund Helbok,Klaus Galiano,Claudia Pleifer,Bettina Pfausler,Christian Brenneis,Christian W. Huck,K. Engelhardt,Alois Obwegeser,Erich Schmutzhard +11 more
TL;DR: This pilot study indicates that EVD catheters impregnated with silver nanoparticles might be a new option for preventing CAV in neurocritical care patients, and therefore evaluation in a large prospective randomized study is warranted.
Journal ArticleDOI
Efficacy and safety of erenumab (AMG334) in episodic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study.
Peter J. Goadsby,Koen Paemeleire,Gregor Broessner,Jan Lewis Brandes,Jan Klatt,Feng Zhang,Hernan Picard,Robert A. Lenz,Daniel D. Mikol +8 more
TL;DR: Erenumab showed consistent efficacy in episodic migraine patients who had failed prior preventive treatments and was well tolerated across subgroups, and the data suggest prior patients with prior treatment failures have lower placebo response rates.